| 000 | 01691 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511205022.0 | ||
| 264 | 0 | _c19920604 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0006-8993 | ||
| 024 | 7 |
_a10.1016/0006-8993(91)91469-h _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOno, H | |
| 245 | 0 | 0 |
_aAmphetamine-antagonistic properties of 4-phenyl-1,2,3,4- tetrahydroisoquinoline: inhibition of spinal reflex-enhancing effects of methamphetamine, phenylethylamine and nomifensine. _h[electronic resource] |
| 260 |
_bBrain research _cNov 1991 |
||
| 300 |
_a319-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmphetamine _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aDecerebrate State |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethamphetamine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNomifensine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhenethylamines _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPrazosin _xpharmacology |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 |
_aReflex, Monosynaptic _xdrug effects |
| 650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
| 650 | 0 | 4 | _aTetrahydroisoquinolines |
| 700 | 1 | _aHasebe, Y | |
| 700 | 1 | _aSatoh, M | |
| 700 | 1 | _aNagao, T | |
| 700 | 1 | _aOhta, S | |
| 700 | 1 | _aHirobe, M | |
| 700 | 1 | _aFuduka, H | |
| 773 | 0 |
_tBrain research _gvol. 564 _gno. 2 _gp. 319-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-8993(91)91469-h _zAvailable from publisher's website |
| 999 |
_c1816856 _d1816856 |
||